Tanshinone IIA decreases the protein expression of EGFR, and IGFR blocking the PI3K/Akt/mTOR pathway in gastric carcinoma AGS cells both in vitro and in vivo
Chin‐Cheng Su(Changhua Christian Hospital), Tsung‐Lang Chiu(Tzu Chi University)
Cited by 58
Related Papers
Magnetic Core–Shell Nanocapsules with Dual‐Targeting Capabilities and Co‐Delivery of Multiple Drugs to Treat Brain Gliomas
|Advanced Healthcare Materials|2014|119
Tanshinone IIA inhibits gastric carcinoma AGS cells by decreasing the protein expression of VEGFR and blocking Ras/Raf/MEK/ERK pathway
|International Journal of Molecular Medicine|2018|38
Tanshinone IIA increases protein expression levels of PERK, ATF6, IRE1α, CHOP, caspase-3 and caspase-12 in pancreatic cancer BxPC-3 cell-derived xenograft tumors
|Molecular Medicine Reports|2017|32
Sann-Joong-Kuey-Jian-Tang inhibits hepatocellular carcinoma Hep-G2 cell proliferation by increasing TNF-α, Caspase-8, Caspase- 3 and Bax but by decreasing TCTP and Mcl-1 expression in vitro
|Molecular Medicine Reports|2013|13
Sann-Joong-Kuey-Jian-Tang decreases the protein expression of Mcl-1 and TCTP and increases that of TNF-α and Bax in BxPC-3 pancreatic carcinoma cells
|International Journal of Molecular Medicine|2013|5